Forecasting Impact
Forecasting Impact is a monthly podcast that aims to disseminate the science and practice of forecasting alongside prominent academics and practitioners in the field. Our vision is to grow the forecasting community, foster collaboration between academia and industry, and promote scientific forecasting and good practice. We’ll discuss a variety of topics in economics, supply chain, energy, AI, data analytics, healthcare, and more.
Podcast Team: Dr. Mahdi Abolghasemi, Dr. Sevvandi Kandanaarachchi, Michał Chojnowski, Dr Laila Akhlaghi, George Boretos, Mariana Menchero, Dr. Faranak Golestaneh, Arian Sultan Khan.
Future guests: if you have something interesting on forecasting to share with our audiences, please send an email to forecastingimpact@gmail.com
Forecasting Impact
Forecasting in Healthcare with Hema Srinivasan
In this episode, hosts Arian Sultan and Laila Akhlaghi discuss financial tools that enable healthcare markets to function more efficiently and how forecasting plays an important role in their execution with Hema Srinivasan of MedAccess. Hema Srinivasan is a senior advisor to MedAccess, supporting work to identify and execute opportunities for financial tools to help lower prices and increase the availability of medical products. She supports the Health Markets team in sourcing and developing pipeline opportunities for the deployment of MedAccess’ tools, managing the monitoring and implementation of transactions post-execution, and analyzing development impact throughout the partnership development and implementation process.
This episode explores her career and how she has used forecasting to develop market-shaping mechanisms and the methodologies that have led to increases in access to life-saving medical products. This includes analyzing market failures, identifying leverage points for intervention, and implementing policies or programs to rectify imbalances. The episode discusses how these interventions can lead to sustainable and scalable impacts, particularly in sectors where market inefficiencies hinder progress. It highlights interventions that lower prices and increase access to pharmaceuticals, diagnostics, and other medical products in low and middle-income countries (LMICs).